| RS1292115878 |
DENND5A
|
Health Risk |
Pathogenic |
— |
| RS1292147160 |
INVS
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1292160956 |
CDKN1B
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia type 4, Hereditary cancer-predisposing syndrome |
| RS1292183482 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy 1, Glycine encephalopathy 1 |
| RS1292201259 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1292204269 |
G6PC1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS1292210350 |
COQ8B
|
Health Risk |
Pathogenic |
— |
| RS1292231609 |
LAMB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cobblestone lissencephaly without muscular or ocular involvement, Cobblestone lissencephaly without muscular or ocular involvement |
| RS1292239409 |
BLM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Bloom syndrome |
| RS1292246271 |
CEP290
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS1292248431 |
POMT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2 |
| RS1292267151 |
F5
|
Health Risk |
Likely pathogenic |
F5-related disorder, F5-related disorder |
| RS1292283693 |
KIAA1549
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1292294409 |
CTNNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1292326578 |
RNPC3
|
Health Risk |
Likely pathogenic |
Isolated growth hormone deficiency, type 5 |
| RS1292339242 |
BPTF
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1292344717 |
OPLAH
|
Health Risk |
Pathogenic |
5-Oxoprolinase deficiency, 5-Oxoprolinase deficiency |
| RS1292367136 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS1292379905 |
AARS1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1292401633 |
POLR3A
|
Health Risk |
Pathogenic/Likely pathogenic |
Leukodystrophy, Leukodystrophy |
| RS1292403369 |
ALDH18A1
|
Health Risk |
Likely pathogenic |
Autosomal dominant spastic paraplegia type 9, de Barsy syndrome |
| RS1292407171 |
HPS3
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS1292415045 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Adult hypophosphatasia, Childhood hypophosphatasia |
| RS1292452485 |
PCCB
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1292456827 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS1292460656 |
SLC12A6
|
Health Risk |
Pathogenic/Likely pathogenic |
SLC12A6-related disorder, SLC12A6-related disorder |
| RS1292463430 |
ADGRG1
|
Health Risk |
Pathogenic |
— |
| RS1292477918 |
SKIC3
|
Health Risk |
Pathogenic |
— |
| RS1292482268 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1292516576 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel syndrome, type 6 |
| RS1292517709 |
EGFR
|
Health Risk |
Likely pathogenic |
Lung adenocarcinoma, Lung adenocarcinoma |
| RS1292531971 |
LAMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Danon disease |
| RS1292534396 |
COG6
|
Health Risk |
Pathogenic/Likely pathogenic |
COG6-congenital disorder of glycosylation, Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome |
| RS1292541006 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS1292551263 |
TBC1D24
|
Health Risk |
Pathogenic/Likely pathogenic |
6 conditions, Developmental and epileptic encephalopathy |
| RS1292553472 |
CTNNA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 13, Arrhythmogenic right ventricular dysplasia 13 |
| RS1292568038 |
TGM1
|
Health Risk |
Pathogenic |
— |
| RS1292577132 |
MPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS1292580496 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1292600354 |
CYP27B1
|
Health Risk |
Pathogenic |
— |
| RS1292608555 |
STX11
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hemophagocytic lymphohistiocytosis 4, Familial hemophagocytic lymphohistiocytosis 4 |
| RS1292609217 |
SYNGAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 5 |
| RS1292617227 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS1292636769 |
GNPTG
|
Health Risk |
Conflicting classifications of pathogenicity |
GNPTG-mucolipidosis, Inborn genetic diseases |
| RS1292645984 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 11 |
| RS1292646768 |
HADH
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Deficiency of 3-hydroxyacyl-CoA dehydrogenase, Hyperinsulinemic hypoglycemia |
| RS1292663596 |
OBSL1
|
Health Risk |
Pathogenic/Likely pathogenic |
3M syndrome 2, 3M syndrome 2 |
| RS1292664749 |
ADGRV1
|
Health Risk |
Pathogenic |
Retinal dystrophy, ADGRV1-related disorder |
| RS1292667374 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1292668105 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS1292670477 |
TNFRSF11B
|
Health Risk |
Pathogenic |
— |
| RS1292672301 |
TWNK
|
Health Risk |
Pathogenic |
— |
| RS1292684996 |
WDPCP
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1292721679 |
PHKB
|
Health Risk |
Pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS1292724234 |
IRF2BPL
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS1292748326 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1292757961 |
DNAAF19
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 17 |
| RS1292759098 |
ACOX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Acyl-CoA oxidase deficiency, Mitchell syndrome |
| RS1292802544 |
FAM161A
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1292827495 |
USB1
|
Health Risk |
Pathogenic |
Poikiloderma with neutropenia, Poikiloderma with neutropenia |
| RS1292831710 |
RECQL4
|
Health Risk |
Pathogenic |
Baller-Gerold syndrome, Baller-Gerold syndrome |
| RS1292866391 |
KLHL40
|
Health Risk |
Pathogenic |
Nemaline myopathy 8, Nemaline myopathy 8 |
| RS1292874452 |
DRAM2
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1292908960 |
ETFDH
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS1292921760 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS1292940121 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, Werner syndrome |
| RS1292941352 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Brittle cornea syndrome 1 |
| RS1292946504 |
NKX2-1
|
Health Risk |
Likely pathogenic |
Brain-lung-thyroid syndrome, Brain-lung-thyroid syndrome |
| RS1292953164 |
GALNT12
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1292988272 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1293009471 |
PIGG
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS1293033867 |
SLC18A2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1293048695 |
TNFRSF13B
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS1293077915 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1293079271 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Noonan syndrome 4 |
| RS1293081480 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS1293095681 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1293098417 |
EVC
|
Health Risk |
Likely pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS1293099867 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS12931021 |
ZFHX3
|
Health Risk |
risk factor |
Atrial fibrillation, familial |
| RS1293110437 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1293118415 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS1293165449 |
TBCD
|
Health Risk |
Pathogenic |
— |
| RS1293202153 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1293214060 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1293215555 |
IDUA
|
Health Risk |
Likely pathogenic |
Hurler syndrome, Mucopolysaccharidosis type 1 |
| RS1293236067 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHARGE syndrome |
| RS1293245717 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS1293246328 |
ASH1L
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 52 |
| RS1293255485 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1293262938 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1293268696 |
ITGB2
|
Health Risk |
Likely pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS1293271804 |
ATP13A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Kufor-Rakeb syndrome, Autosomal recessive spastic paraplegia type 78 |
| RS1293276034 |
NOTCH1
|
Health Risk |
Likely pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS1293288101 |
BPNT2
|
Health Risk |
Pathogenic |
— |
| RS1293303410 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS1293305047 |
PKD1
|
Health Risk |
Likely pathogenic |
PKD1-related disorder, Polycystic kidney disease |
| RS1293309607 |
ACADM
|
Health Risk |
Conflicting classifications of pathogenicity |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1293317548 |
AP4M1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 50, Hereditary spastic paraplegia |
| RS1293340864 |
KIFBP
|
Health Risk |
Pathogenic |
Goldberg-Shprintzen syndrome, Goldberg-Shprintzen syndrome |